APA (7th ed.) Citation

M, E., TM, N., H, K., K, N., Y, T., K, I., . . . Y, Y. (2026). Clindamycin demonstrates clinical effectiveness for bacteremic M1UKStreptococcus pyogenes pneumonia: A case report and in vitro evidence of notable antitoxin effects on M1UK. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 168, 108742. https://doi.org/10.1016/j.ijid.2026.108742

Chicago Style (17th ed.) Citation

M, Ezaki, et al. "Clindamycin Demonstrates Clinical Effectiveness for Bacteremic M1UKStreptococcus Pyogenes Pneumonia: A Case Report and in Vitro Evidence of Notable Antitoxin Effects on M1UK." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 168 (2026): 108742. https://doi.org/10.1016/j.ijid.2026.108742.

MLA (9th ed.) Citation

M, Ezaki, et al. "Clindamycin Demonstrates Clinical Effectiveness for Bacteremic M1UKStreptococcus Pyogenes Pneumonia: A Case Report and in Vitro Evidence of Notable Antitoxin Effects on M1UK." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 168, 2026, p. 108742, https://doi.org/10.1016/j.ijid.2026.108742.